Nuevocor
About:
Nuevocor operates as a preclinical-stage biotech company.
Website: https://www.nuevocor.com/
Top Investors: EDBI, Xora Innovation, Boehringer Ingelheim Venture Fund, Seeds Capital, EVX Ventures
Description:
Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
Total Funding Amount:
$35.6M
Headquarters Location:
Singapore, Central Region, Singapore
Founded Date:
2020-01-01
Founders:
Brian Burke, Colin Stewart, Jianming Jiang, Mark Kay, XiangQian (XQ) Lin, Yann Chong Tan, Yin Loon Lee
Number of Employees:
11-50
Last Funding Date:
2022-11-03
IPO Status:
Private
Industries:
© 2025 bioDAO.ai